ACSS3 promotes the tumorigenesis of non-small cell lung cancer via suppressing p53-mediated ferroptosis

This publication has 39 references indexed in Scilit:

• ACSS3 in brown fat drives propionate catabolism and its deficiency leads to autophagy and systemic metabolic dysfunction
  Clinical and Translational Medicine, 2022
• Lung cancer
  The Lancet, 2021
• Cystine transporter SLC7A11/xCT in cancer: ferroptosis, nutrient dependency, and cancer therapy
  Protein & Cell, 2020
• Mitochondrial Metabolism as a Target for Cancer Therapy
  Cell Metabolism, 2020
• Role of Mitochondria in Ferroptosis
  Molecular Cell, 2019
• Mitochondrial Acetyl‐CoA Synthetase 3 is Biosignature of Gastric Cancer Progression
  Cancer Medicine, 2018
• Acyl‐CoA synthetase short‐chain family member 2 (ACSS2) is regulated by SREBP‐1 and plays a role in fatty acid synthesis in caprine mammary epithelial cells
  Journal of Cellular Physiology, 2017
• Current Challenges in Cancer Treatment
  Clinical Therapeutics, 2016
• Acetate Is a Bioenergetic Substrate for Human Glioblastoma and Brain Metastases
  Cell, 2014
• Non-Small Cell Lung Cancer: Epidemiology, Risk Factors, Treatment, and Survivorship
  Mayo Clinic Proceedings, 2008